Altria Group (MO) Shareholder Verus Financial Partners Lifted Position by $628,852; Ativo Capital Management Has Increased Its Anika Therapeutics (ANIK) Holding by $369,607

December 18, 2017 - By Maria Brooks

Ativo Capital Management Llc increased its stake in Anika Therapeutics Inc (ANIK) by 62.85% based on its latest 2017Q2 regulatory filing with the SEC. Ativo Capital Management Llc bought 7,543 shares as the company’s stock declined 3.98% while stock markets rallied. The institutional investor held 19,545 shares of the medical and dental instruments company at the end of 2017Q2, valued at $964,000, up from 12,002 at the end of the previous reported quarter. Ativo Capital Management Llc who had been investing in Anika Therapeutics Inc for a number of months, seems to be bullish on the $783.53M market cap company. The stock increased 1.27% or $0.67 during the last trading session, reaching $53.44. About 156,605 shares traded or 128.92% up from the average. Anika Therapeutics, Inc. (NASDAQ:ANIK) has risen 4.53% since December 18, 2016 and is uptrending. It has underperformed by 12.17% the S&P500.

Verus Financial Partners Inc increased its stake in Altria Group Inc (MO) by 10.95% based on its latest 2017Q2 regulatory filing with the SEC. Verus Financial Partners Inc bought 8,498 shares as the company’s stock declined 2.84% while stock markets rallied. The institutional investor held 86,078 shares of the farming and seeds and milling company at the end of 2017Q2, valued at $6.41M, up from 77,580 at the end of the previous reported quarter. Verus Financial Partners Inc who had been investing in Altria Group Inc for a number of months, seems to be bullish on the $136.76B market cap company. The stock decreased 0.17% or $0.12 during the last trading session, reaching $71.67. About 14.17M shares traded or 102.57% up from the average. Altria Group, Inc. (NYSE:MO) has risen 11.92% since December 18, 2016 and is uptrending. It has underperformed by 4.78% the S&P500.

Since August 10, 2017, it had 0 buys, and 2 sales for $2.95 million activity. DEVITRE DINYAR S also sold $1.96 million worth of Altria Group, Inc. (NYSE:MO) shares.

Among 19 analysts covering Altria Group Inc. (NYSE:MO), 13 have Buy rating, 0 Sell and 6 Hold. Therefore 68% are positive. Altria Group Inc. had 51 analyst reports since July 31, 2015 according to SRatingsIntel. The rating was initiated by Berenberg with “Buy” on Tuesday, June 14. The company was upgraded on Wednesday, January 4 by Bank of America. Piper Jaffray maintained the shares of MO in report on Thursday, July 27 with “Buy” rating. The firm has “Sector Perform” rating by RBC Capital Markets given on Monday, July 31. The rating was initiated by Citigroup with “Buy” on Tuesday, September 13. The stock of Altria Group, Inc. (NYSE:MO) has “Buy” rating given on Monday, October 30 by Citigroup. The firm earned “Buy” rating on Monday, June 27 by Stifel Nicolaus. Jefferies maintained the stock with “Hold” rating in Friday, November 17 report. RBC Capital Markets maintained the stock with “Sell” rating in Friday, May 26 report. Barclays Capital maintained Altria Group, Inc. (NYSE:MO) rating on Thursday, March 30. Barclays Capital has “Equal Weight” rating and $74 target.

Investors sentiment increased to 0.91 in 2017 Q2. Its up 0.01, from 0.9 in 2017Q1. It increased, as 63 investors sold MO shares while 529 reduced holdings. 97 funds opened positions while 444 raised stakes. 1.16 billion shares or 0.78% less from 1.17 billion shares in 2017Q1 were reported. First Hawaiian Bank & Trust holds 0.05% or 4,346 shares. Fmr Ltd Liability Com holds 14.59M shares or 0.14% of its portfolio. Wagner Bowman Mngmt holds 0.79% or 37,754 shares in its portfolio. Wall Street Access Asset Ltd Llc reported 0.84% in Altria Group, Inc. (NYSE:MO). Macquarie Grp reported 0.01% of its portfolio in Altria Group, Inc. (NYSE:MO). Pioneer Trust State Bank N A Or owns 8,764 shares for 0.36% of their portfolio. Morgan Stanley invested in 19.92M shares. 2,176 are held by Camarda Advsr Ltd. Financial Bank has invested 0.8% in Altria Group, Inc. (NYSE:MO). Hodges Management reported 0.02% stake. Orca Inv Ltd Llc has invested 1.38% of its portfolio in Altria Group, Inc. (NYSE:MO). Keating Investment Counselors Incorporated accumulated 0.62% or 19,040 shares. Westpac Banking Corporation invested in 0% or 130,062 shares. Ct Mason stated it has 33,274 shares or 0.99% of all its holdings. Primecap Management Ca, a California-based fund reported 171,300 shares.

Verus Financial Partners Inc, which manages about $469.81M and $247.83M US Long portfolio, decreased its stake in Vanguard Index Fds (VO) by 6,795 shares to 53,868 shares, valued at $7.68 million in 2017Q2, according to the filing.

Since October 12, 2017, it had 0 insider buys, and 4 sales for $2.52 million activity.

Investors sentiment decreased to 1.14 in 2017 Q2. Its down 0.12, from 1.26 in 2017Q1. It dropped, as 16 investors sold ANIK shares while 48 reduced holdings. 20 funds opened positions while 53 raised stakes. 12.24 million shares or 3.97% more from 11.77 million shares in 2017Q1 were reported. Swiss Commercial Bank invested 0% in Anika Therapeutics, Inc. (NASDAQ:ANIK). First Republic Inc, California-based fund reported 40,572 shares. Ngam Advsrs Lp stated it has 0.05% of its portfolio in Anika Therapeutics, Inc. (NASDAQ:ANIK). Goldman Sachs Inc holds 31,172 shares. Virginia-based Bb&T Ltd Liability Com has invested 0.01% in Anika Therapeutics, Inc. (NASDAQ:ANIK). Panagora Asset Mgmt holds 0% in Anika Therapeutics, Inc. (NASDAQ:ANIK) or 1,315 shares. State Common Retirement Fund holds 15,400 shares. Thomson Horstmann And Bryant Inc holds 229,944 shares or 1.47% of its portfolio. Kennedy Cap holds 0.03% or 36,872 shares in its portfolio. Cap Mngmt Corp Va owns 61,030 shares or 0.9% of their US portfolio. Moreover, Bokf Na has 0.01% invested in Anika Therapeutics, Inc. (NASDAQ:ANIK). Voya Investment Management Lc holds 0% or 7,499 shares in its portfolio. Bnp Paribas Arbitrage, a New York-based fund reported 4,315 shares. Public Sector Pension Inv Board owns 7,547 shares. Eaton Vance Mngmt holds 0% in Anika Therapeutics, Inc. (NASDAQ:ANIK) or 5,726 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: